$MSON News

Last published 5y ago

5y agoBVS MSONBioventus and Misonix Stockholders Approve the Acquisition of Misonix by BioventusGlobeNewswireDURHAM, N.C. and FARMINGDALE, N.Y., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) ("Bioventus" or the "Company"), a global leader in innovations for active healing, and Misonix, Inc. (NASDAQ:MSON) ("Misonix"), a provider of minimally in
5y agoBVS MSONBIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger ConsiderationGlobeNewswireDURHAM, N.C. and FARMINGDALE, N.Y., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) and Misonix, Inc. (NASDAQ:MSON) ("Misonix"), today announced an election deadline of 5:00 p.m., New York City Time, on October 25, 2021 (the "Election Dea
5y agoDSPG DVCR GLBL MSONMoore Kuehn Encourages GLBL, DSPG, DVCR, and MSON Investors to Contact Law FirmPR NewswireNEW YORK, Sept. 28, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to sha
5y agoLMRK MSON SAFM SVBIMoore Kuehn Encourages MSON, LMRK, SAFM, and SVBI Investors to Contact Law FirmGlobeNewswireNEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair
5y agoBVS MSONMisonix Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsGlobeNewswireFARMINGDALE, N.Y., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) ("Misonix" or the "Company"), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today repo
5y agoBVS MSONBioventus and Misonix Announce Definitive Agreement for Bioventus to Acquire MisonixGlobeNewswireSignificantly Expands TAM and Adds Considerable Scale and Scope in Spine and Lower Extremity Enhances Surgical Solutions Vertical by Adding Minimally Invasive Ultrasonic Technologies That Improve Clinical Outcomes Deepens Restorative Therapies Vertica
5y agoBVS MSONMisonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue ResultsGlobeNewswireFARMINGDALE, N.Y., July 29, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) ("Misonix" or the "Company"), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes today announ
5y agoBVS MSONBioventus Inc. Reports Preliminary Second Quarter Net Sales; Updates Full-Year 2021 Net Sales GuidanceGlobeNewswireDURHAM, N.C., July 29, 2021 (GLOBE NEWSWIRE) -- Bioventus Inc. (NASDAQ:BVS) ("Bioventus" or "the Company"), a global leader in innovations for active healing, today reported preliminary financial results for the three months ended July 3, 2021.
5y agoMSONMisonix Appoints Patrick J. Beyer to Board of DirectorsGlobeNewswireFARMINGDALE, N.Y., May 14, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) ("Misonix" or the "Company"), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announ
5y agoMSONMisonix to Participate in Upcoming May and June Virtual Investor ConferencesGlobeNewswireFARMINGDALE, N.Y., May 10, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Offi
5y agoMSONMisonix Reports Fiscal 2021 Third Quarter Financial ResultsGlobeNewswireFARMINGDALE, N.Y., May 06, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON) ("Misonix" or the "Company"), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today report
5y agoMSONMisonix, Inc. to Host Earnings CallACCESS NewswireNEW YORK, NY / ACCESSWIRE / May 6, 2021 / Misonix, Inc. (NASDAQ:MSON) will be discussing their earnings results in their 2021 Third Quarter Earnings call to be held on May 6, 2021 at 4:30 PM Eastern Time. To listen to the event live or access a replay o
5y agoMSONMisonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6GlobeNewswireFARMINGDALE, N.Y., April 20, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ:MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report it
5y agoMSONMISONIX, INCORPORATED - Appeal, AffirmedUS Patent Trial and Appeal Board
5y agoMSONMisonix Expands Ultrasonic Technology Capabilities to Address the Orthoplastics MarketGlobeNewswireFARMINGDALE, N.Y., March 30, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
5y agoMSONMisonix Receives Health Canada Approval for neXusGlobeNewswireFARMINGDALE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
5y agoMSONMisonix to Participate in Upcoming March Investor ConferencesGlobeNewswireFARMINGDALE, N.Y., March 01, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
5y agoMSONMisonix to Participate at Upcoming Investor ConferencesGlobeNewswireFARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
5y agoMSONMisonix Reports Fiscal 2021 Second Quarter Financial ResultsGlobeNewswireFARMINGDALE, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
5y agoMSONMisonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4GlobeNewswireFARMINGDALE, N.Y., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
5y agoMSONMisonix to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireFARMINGDALE, N.Y., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
5y agoMSONMisonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered LivesGlobeNewswireFARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that...
5y agoMSONMisonix to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewswireFARMINGDALE, N.Y., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix to Participate at Upcoming Craig-Hallum and Canaccord Genuity Investor ConferencesGlobeNewswireFARMINGDALE, N.Y., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix Fiscal 2021 First Quarter Revenue Rises 59% to $17.7 MillionGlobeNewswireFARMINGDALE, N.Y., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix to Report Fiscal 2021 First Quarter Financial Results and Host Conference Call and Webcast on November 5GlobeNewswireFARMINGDALE, N.Y., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix Reports Preliminary Fiscal 2021 First Quarter Revenue of Approximately $17.7 MillionGlobeNewswireFARMINGDALE, N.Y., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix,” the “Company,” “we,” “us” or “our”), a provider of minimally invasive therapeutic ultrasonic medical...
6y agoMSONMisonix Enters Into Exclusive Supply and Distribution Agreement With Gunze Limited for TheraGenesis® Bilayer Wound MatrixGlobeNewswireFARMINGDALE, N.Y., Sept. 21, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix”) a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue...
6y agoMSONMisonix to Present at the Cantor Virtual Global Healthcare ConferenceGlobeNewswireFARMINGDALE, N.Y., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix Reports Fourth Quarter and Fiscal Year 2020 ResultsGlobeNewswireFARMINGDALE, N.Y., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix to Report Fiscal 2020 Fourth Quarter Financial Results and Host Conference Call and Webcast on September 3GlobeNewswireFARMINGDALE, N.Y., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix to Present at the 40th Annual Canaccord Genuity Growth ConferenceGlobeNewswireFARMINGDALE, N.Y., July 30, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance...
6y agoMSONMisonix Reports Preliminary Fiscal 2020 Fourth Quarter Revenue of Approximately $13.5 MillionGlobeNewswireFull Year Revenue of Approximately $62.3 Million Company Focus on Shareholder Value Creation, Cash Preservation, Expense Reduction, Workforce Efficiency and Operational Synergies FARMINGDALE,...
6y agoMSONFaruqi & Faruqi, LLP is Investigating Misonix, Inc. (MSON) on Behalf of its ShareholdersGlobeNewswireNEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Misonix, Inc. (“Misonix” or the “Company”)...
6y agoMSONMisonix to Present at the 17th Annual Craig Hallum Institutional Investor Conference On May 27GlobeNewswireFARMINGDALE, N.Y., May 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix to Report Fiscal 2020 Third Quarter Financial Results and Host Conference Call and Webcast on May 11GlobeNewswireFARMINGDALE, N.Y., May 06, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMISONIX REPORTS PRELIMINARY FISCAL 2020 THIRD QUARTER REVENUE OF APPROXIMATELY $17.9 MILLIONGlobeNewswireWith Focus on Maintaining Our Objective of Shareholder Value Creation, Company to Prioritize Cash Preservation Through Expense Reduction, Workforce Efficiency and Operational Synergies ...
6y agoMSONMisonix to Present at the 40th Annual Cowen Healthcare Conference on March 2GlobeNewswireFARMINGDALE, N.Y., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
6y agoMSONMisonix Reports Record Quarterly Revenue of $19.7 Million for Fiscal 2020 Second QuarterGlobeNewswireFARMINGDALE, N.Y., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix to Report Fiscal 2020 Second Quarter Financial Results And Host Conference Call and Webcast on February 5GlobeNewswireFARMINGDALE, N.Y., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix Announces Pricing of Public Offering of Common StockGlobeNewswireFARMINGDALE, N.Y., Jan. 23, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix Announces Public Offering of Common StockGlobeNewswireFARMINGDALE, N.Y., Jan. 22, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix Reports Preliminary Fiscal 2020 Second Quarter Revenue of Approximately $19.7 MillionGlobeNewswireFARMINGDALE, N.Y., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoCRY MSONCryoLife and Misonix Enter Into Distribution Agreement for NeoPatchPR NewswireCryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has entered ...
6y agoMSONMisonix to Present at 38th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireFARMINGDALE, N.Y., Dec. 17, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
6y agoMSONMisonix Announces Results of New Large Real-World Studies That Further Prove the Clinical Effectiveness of TheraSkinGlobeNewswireFARMINGDALE, N.Y., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and...
7y agoMSONMisonix, Inc. Completes Acquisition of Regenerative Medical Company Solsys MedicalGlobeNewswireFARMINGDALE, N.Y., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
7y agoMSONMisonix Reports Fourth Quarter and Fiscal Year 2019 ResultsGlobeNewswireFARMINGDALE, N.Y., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
7y agoMSONMisonix Announces CE Mark Approval for NexusGlobeNewswireFARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance...
7y agoMSONMisonix' (MSON) CEO Stavros Vizirgianakis on Acquisition of Solsys Medical - TranscriptEarnings Call Transcripts